Current progress in cancer immunotherapy based on natural killer cells.

Bagheri, Yasin; Barati, Alireza; Aghebati-Maleki, Ali; Aghebati-Maleki, Leili; Yousefi, Mehdi

Bagheri, Yasin; Barati, Alireza; Aghebati-Maleki, Ali; Aghebati-Maleki, Leili; Yousefi, Mehdi.

Afiliação

Bagheri Y; Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Barati A; Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Aghebati-Maleki A; Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Aghebati-Maleki L; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Yousefi M; Student's Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.

Cell Biol Int ; 45(1): 2-17, 2021 Jan.

Article em En | MEDLINE | ID: mdl-32910474

Assuntos

Imunoterapia; Células Matadoras Naturais/imunologia; Neoplasias/imunologia; Neoplasias/terapia; Humanos; Evasão da Resposta Imune/imunologia; Neoplasias/patologia; Receptores de Antígenos Quiméricos/metabolismo

Palavras-chave

activating receptors; cancer; chimeric antigen receptors; clinical application; inhibitory receptors; natural killer cells

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Imunoterapia / Neoplasias Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google